Praxis Precision Medicines (PRAX) Change in Accured Expenses (2019 - 2026)

Praxis Precision Medicines' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at -$17.4 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 109.96% year-over-year to -$17.4 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 75.17% decrease from a year earlier, with the FY2025 full-year figure at $11.2 million, down 30.48% from the prior year.
• Change in Accured Expenses retreated to -$17.4 million in Q1 2026 per PRAX's latest filing, from $14.4 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $14.4 million in Q4 2025 and bottomed at -$17.4 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is $374000.0 (2023), against an average of -$531588.2.
• Across the five-year window, Change in Accured Expenses sank 1491.64% in 2022 and jumped 2067.11% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at -$2.0 million in 2022, then surged by 118.39% to $374000.0 in 2023, then soared by 2067.11% to $8.1 million in 2024, then jumped by 78.01% to $14.4 million in 2025, then tumbled by 220.49% to -$17.4 million in 2026.
• Per Business Quant, the three latest PRAX Change in Accured Expenses figures stand at -$17.4 million (Q1 2026), $14.4 million (Q4 2025), and $1.6 million (Q3 2025).